Womack Financial LLC purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 5,358 shares of the company’s stock, valued at approximately $689,000.
Several other institutional investors and hedge funds have also bought and sold shares of the business. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in shares of Merck KGaA during the second quarter valued at approximately $942,087,000. Bank of Nova Scotia purchased a new stake in Merck KGaA in the second quarter worth $281,696,000. Danske Bank A S bought a new stake in Merck KGaA in the second quarter valued at $276,535,000. Cullen Capital Management LLC purchased a new position in Merck KGaA during the 2nd quarter valued at $259,158,000. Finally, Korea Investment CORP purchased a new position in Merck KGaA during the 2nd quarter valued at $239,191,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.1%
Shares of OTCMKTS MKGAF opened at $163.45 on Tuesday. The firm has a fifty day simple moving average of $162.78 and a two-hundred day simple moving average of $148.59. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $21.12 billion, a PE ratio of 24.95 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
